Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

34.45
+0.14000.41%
Post-market: 34.35-0.1000-0.29%19:58 EDT
Volume:153.67K
Turnover:5.42M
Market Cap:42.66M
PE:- -
High:37.34
Open:34.76
Low:33.45
Close:34.31
52wk High:152.22
52wk Low:11.52
Shares:1.24M
Float Shares:1.24M
Volume Ratio:0.77
T/O Rate:12.41%
Dividend:3.85
Dividend Rate:11.17%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Tempus AI Director Nadja West Disposes of 3,000 Common Shares Worth $161,700

Reuters
·
Aug 19

30-Year Treasury Yield Hits 5.31%: The Triple Squeeze Of Oil, Deficits And AI Debt

Macro World​
·
Aug 18

BofA's Hartnett: The 2026 Midterms Will Decide It — AI Bull Market Either Melts Up Into 2027, Or Drops More Than 10%

AI Industry Frontlines
·
Aug 14

Is The Token No Longer The Yardstick? OpenAI And Anthropic Are Rewriting The Rules For Premium AI

AI Industry Frontlines
·
Aug 14

AI Software Shares Jump. AppLovin, Cloudflare up Around 4%; Palantir up over 3%; Trade Desk, Datadog, Shopify, Duolingo up over 2%

Tiger Newspress
·
Aug 13

Tempus AI CEO Data Ryan Fukushima Disposes of 20.000 Shares Worth $1 Juta

Reuters
·
Aug 12

AI Software Shares Rise. Tempus AI up 7%; Datadag up Nearly 5%; Spotify, Duolingo, Braze up over 4%; Roblox, Snowflake, Figma up over 2%

Tiger Newspress
·
Aug 10

Tempus AI (TEM) After CellCarta Deal And PRISM2 Validation Faces A Fresh Valuation Test

Simply Wall St.
·
Aug 10

Why Tempus AI (TEM) Is Up 18.6% After Joining CellCarta’s CDx Commercialization Lab Network

Simply Wall St.
·
Aug 08

Cellcarta: Adds Tempus to Cdx Commercialization Lab Network as Second Commercial Lab Partner

THOMSON REUTERS
·
Aug 06

Tempus AI CEO, Data Ryan Fukushima Reports Disposal of 23,818 Common Shares Worth $1.1 Million

Reuters
·
Aug 06

Tempus AI announces study results of PRISM2

TIPRANKS
·
Aug 04

Tempus AI Inc : Btig Cuts Target Price to $70 from $80

THOMSON REUTERS
·
Aug 04

JPMorgan: The AI Trade Won't Lead the Market in the Second Half

Analyst Calls
·
Aug 04

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Aug 04

Tempus AI price target lowered to $56 from $64 at H.C. Wainwright

TIPRANKS
·
Aug 04

Tempus AI is Maintained at Hold by Stifel

Dow Jones
·
Aug 03

Tempus AI–Personalis Deal: Integration Risks, Rising Costs, and Regulatory Scrutiny Could Undermine Synergy Gains

TIPRANKS
·
Aug 01

Tempus AI Price Target Maintained with a $75.00/Share by Needham

Dow Jones
·
Jul 31

Tempus AI Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31